Skip to main content
Journal cover image

BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL

Publication ,  Conference
Sandhu, RK; Ezekowitz, J; Andersson, U; Alexander, J; Granger, C; Halvorsen, S; Hanna, M; Hijazi, Z; Jansky, P; Lopes, R; Wallentin, L
Published in: Journal of the American College of Cardiology
March 2015

Duke Scholars

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2015

Volume

65

Issue

10

Start / End Page

A284 / A284

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sandhu, R. K., Ezekowitz, J., Andersson, U., Alexander, J., Granger, C., Halvorsen, S., … Wallentin, L. (2015). BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL. In Journal of the American College of Cardiology (Vol. 65, pp. A284–A284). Elsevier BV. https://doi.org/10.1016/s0735-1097(15)60284-4
Sandhu, Roopinder K., Justin Ezekowitz, Ulrika Andersson, John Alexander, Christopher Granger, Sigrun Halvorsen, Michael Hanna, et al. “BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL.” In Journal of the American College of Cardiology, 65:A284–A284. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60284-4.
Sandhu RK, Ezekowitz J, Andersson U, Alexander J, Granger C, Halvorsen S, et al. BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL. In: Journal of the American College of Cardiology. Elsevier BV; 2015. p. A284–A284.
Sandhu, Roopinder K., et al. “BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL.” Journal of the American College of Cardiology, vol. 65, no. 10, Elsevier BV, 2015, pp. A284–A284. Crossref, doi:10.1016/s0735-1097(15)60284-4.
Sandhu RK, Ezekowitz J, Andersson U, Alexander J, Granger C, Halvorsen S, Hanna M, Hijazi Z, Jansky P, Lopes R, Wallentin L. BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL. Journal of the American College of Cardiology. Elsevier BV; 2015. p. A284–A284.
Journal cover image

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2015

Volume

65

Issue

10

Start / End Page

A284 / A284

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology